Healthcare -
Drug Manufacturers - Specialty & Generic - NASDAQ - US
$ 59.33
-0.386 %
$ 1.25 B
Market Cap
-126.23
P/E
ANIP - COST OF REVENUE
Cost of Revenue ANIP - ANI Pharmaceuticals, Inc.
182 M
LAST VALUE
34.32%
2 YEAR CAGR
19.97%
5 YEAR CAGR
33.66%
10 YEAR CAGR